How have ECTE shares performed in 2024?

Echo Therapeutics' stock was trading at $0.0002 at the start of the year. Since then, ECTE shares have increased by 0.0% and is now trading at $0.0002. View the best growth stocks for 2024 here .

How were Echo Therapeutics' earnings last quarter?

Echo Therapeutics, Inc. (OTCMKTS:ECTE) released its quarterly earnings data on Friday, August, 12th. The medical device company reported ($0.82) earnings per share for the quarter. During the same quarter in the previous year, the business posted ($0.97) EPS.

What other stocks do shareholders of Echo Therapeutics own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Echo Therapeutics investors own include Biocept (BIOC) , DexCom (DXCM) , Rexahn Pharmaceuticals (REXN) , Acer Therapeutics (ACER) , Athersys (ATHX) , LadRx (CYTR) , Glu Mobile (GLUU) , InterCloud Systems (ICLD) , NetApp (NTAP) and

How do I buy shares of Echo Therapeutics?

Shares of ECTE stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here .

OTCMKTS:ECTE

Echo Therapeutics (ECTE) Stock Price, News & Analysis

→ The “Perfect Storm” for Gold (From Gold Safe Exchange) (Ad)

Free ECTE Stock Alerts

$0.0002

0.00 (0.00%)

(As of 09/7/2021)

Compare

Today's Range: $0.0002
▼
$0.0002
50-Day Range: N/A
52-Week Range: $0.00
▼
$0.28

Volume: N/A
Average Volume: N/A
Market Capitalization: N/A

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

Stock Analysis

Get Echo Therapeutics alerts:

Ad Gold Safe Exchange

The “Perfect Storm” for Gold

Gold has already reached all-time highs, and experts believe it's not slowing down any time soon. In fact, some analysts predict a $7,000 price tag by 2025.

Click here now to download the free Precious Metals Buying Guide!

About Echo Therapeutics Stock (OTCMKTS:ECTE)

Echo Therapeutics, Inc. is a medical device company, which engages in the development of non-invasive, and wireless continuous glucose monitoring system for use in the diabetes outpatient market. It offers needle-free skin preparation device as a platform technology that allows for enhanced skin permeation enabling extraction of analytes, such as glucose and delivery of topical pharmaceuticals. The company was founded in 1989 and is headquartered in Iselin, NJ.

ECTE Stock Price History

30 days | 90 days | 365 days | Advanced Chart

ECTE Stock News Headlines

December 9, 2023 | bbc.co.uk

What are echo chambers?

December 3, 2023 | investing.com

ECTE/USD Synthetic Historical Data

April 20, 2024 | Banyan Hill Publishing (Ad)

Don’t Miss Out on the AI Gold Rush That’s Just Getting Started

“Titan of Tech” Bets Big on Tiny AI Company He’s made as much as 3,250,000% in just three years on companies like Facebook, Airbnb, and PayPal… But our research shows his latest investment could be his most successful venture yet.

October 18, 2023 | investing.com

ECTE Historical Data

July 11, 2023 | cnet.com

Best Smart Speakers for 2023: We Tested Alexa, Google, Apple and More

January 11, 2023 | usatoday.com

In echo of Jan. 6 attack in U.S., Brazilian protesters storm their Congress, high court and palace

November 28, 2022 | yahoo.com

Now is the time to buy an Echo Dot smart speaker on Amazon — prices start at just $14.99, and the newest model is under $40!

November 24, 2022 | yahoo.com

Every Single Echo Dot Black Friday Deal Happening Right Now

April 20, 2024 | Banyan Hill Publishing (Ad)

Don’t Miss Out on the AI Gold Rush That’s Just Getting Started

October 11, 2022 | cnet.com

You Should Buy the 4th-Gen Echo Dot This Prime Day, Not the New One. Here's Why

June 1, 2022 | yahoo.com

Everything we know about how to watch Marvel’s ‘Echo’ on Disney+

August 9, 2021 | barrons.com

Echo Therapeutics Inc.

See More Headlines

Receive ECTE Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Echo Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings: 8/12/2016
Today: 4/19/2024
Fiscal Year End: 12/31/2024

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: OTCMKTS
Sector: Medical
Industry: Electromedical equipment
Sub-Industry: N/A
Current Symbol: OTCMKTS:ECTE
Previous Symbol: NASDAQ:ECTE
CUSIP: N/A
CIK: 1031927
Web: www.echotx.com
Phone: (732) 201-4194
Fax: 215-717-4109
Employees: 17
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): N/A
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: N/A
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: N/A
Return on Assets: N/A

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: N/A
Quick Ratio: N/A

Sales & Book Value

Annual Sales: N/A
Price / Sales: N/A
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: N/A
Price / Book: N/A

Miscellaneous

Outstanding Shares: N/A
Free Float: N/A
Market Cap: N/A
Optionable: Not Optionable
Beta: N/A

The Next 7 Blockbuster Stocks for Growth Investors

Wondering what the next stocks will be that hit it big, with solid fundamentals? Click the link below to learn more about how your portfolio could bloom.

Get This Free Report

Key Executives

Alan Wayne Schoenbart
Chief Financial Officer

Key Competitors

View All Competitors

ECTE Stock Analysis - Frequently Asked Questions

How have ECTE shares performed in 2024?: Echo Therapeutics' stock was trading at $0.0002 at the start of the year. Since then, ECTE shares have increased by 0.0% and is now trading at $0.0002.
View the best growth stocks for 2024 here.
How were Echo Therapeutics' earnings last quarter?: Echo Therapeutics, Inc. (OTCMKTS:ECTE) released its quarterly earnings data on Friday, August, 12th. The medical device company reported ($0.82) earnings per share for the quarter. During the same quarter in the previous year, the business posted ($0.97) EPS.
What other stocks do shareholders of Echo Therapeutics own?: Based on aggregate information from My MarketBeat watchlists, some companies that other Echo Therapeutics investors own include Biocept (BIOC), DexCom (DXCM), Rexahn Pharmaceuticals (REXN), Acer Therapeutics (ACER), Athersys (ATHX), LadRx (CYTR), Glu Mobile (GLUU), InterCloud Systems (ICLD), NetApp (NTAP) and
How do I buy shares of Echo Therapeutics?: Shares of ECTE stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (OTCMKTS:ECTE) was last updated on 4/20/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial